RTW Investments’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,131,835
Closed -$6.4M 72
2023
Q3
$6.4M Hold
2,131,835
0.13% 52
2023
Q2
$5.24M Hold
2,131,835
0.1% 56
2023
Q1
$4.82M Buy
2,131,835
+64,011
+3% +$221K 0.1% 51
2022
Q4
$7.22M Sell
2,067,824
-576,651
-22% -$5.06M 0.15% 54
2022
Q3
$97.9M Buy
2,644,475
+6,894
+0.3% +$191K 2.26% 14
2022
Q2
$50.1M Buy
2,637,581
+97,507
+4% +$2.13M 1.29% 27
2022
Q1
$68.6M Buy
2,540,074
+353,750
+16% +$7.31M 1.42% 27
2021
Q4
$49.3M Buy
2,186,324
+648,298
+42% +$14.4M 0.72% 44
2021
Q3
$40.3M Hold
1,538,026
0.61% 46
2021
Q2
$49.2M Buy
1,538,026
+7,309
+0.5% +$254K 0.74% 35
2021
Q1
$53.9M Buy
1,530,717
+18,044
+1% +$631K 0.84% 35
2020
Q4
$48.5M Buy
1,512,673
+1,336
+0.1% +$45.9K 0.81% 35
2020
Q3
$56.9M Buy
1,511,337
+30,485
+2% +$1.18M 1.37% 21
2020
Q2
$66.3M Buy
1,480,852
+496,310
+50% +$21M 1.86% 17
2020
Q1
$33.6M Buy
984,542
+320,058
+48% +$12.9M 1.45% 25
2019
Q4
$25.9M Buy
+664,484
New +$20.2M 0.98% 28

Other funds holding RLMD